These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 26367469

  • 1. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.
    Sharma N, Kapoor M, Nehru B.
    Behav Brain Res; 2016 Jan 01; 296():177-190. PubMed ID: 26367469
    [Abstract] [Full Text] [Related]

  • 2. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N, Nehru B.
    Mol Neurobiol; 2016 Jul 01; 53(5):3326-3337. PubMed ID: 26081143
    [Abstract] [Full Text] [Related]

  • 3. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
    Sharma N, Nehru B.
    Inflammopharmacology; 2018 Apr 01; 26(2):349-360. PubMed ID: 29027056
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
    Sharma N, Nehru B.
    Neurochem Int; 2015 Aug 01; 87():92-105. PubMed ID: 26055970
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L, Sun F, Huang R, Sun W, Zhang D, Wang Q.
    Redox Biol; 2019 Apr 01; 22():101134. PubMed ID: 30798073
    [Abstract] [Full Text] [Related]

  • 6. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N, Sharma S, Nehru B.
    Inflammopharmacology; 2017 Jun 01; 25(3):351-368. PubMed ID: 28409389
    [Abstract] [Full Text] [Related]

  • 7. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
    Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, Srivastava G, Kumar V, Pandey HP, Singh C.
    Brain Res; 2012 Feb 15; 1438():48-64. PubMed ID: 22244881
    [Abstract] [Full Text] [Related]

  • 8. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
    Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS.
    Brain; 2015 May 15; 138(Pt 5):1247-62. PubMed ID: 25716193
    [Abstract] [Full Text] [Related]

  • 9. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
    Wang J, He C, Wu WY, Chen F, Wu YY, Li WZ, Chen HQ, Yin YY.
    Pharmacol Biochem Behav; 2015 Nov 15; 138():96-103. PubMed ID: 26394281
    [Abstract] [Full Text] [Related]

  • 10. The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: role of inflammatory and oxidative brain damage.
    Ferreira AP, Rodrigues FS, Della-Pace ID, Mota BC, Oliveira SM, Velho Gewehr Cde C, Bobinski F, de Oliveira CV, Brum JS, Oliveira MS, Furian AF, de Barros CS, Ferreira J, Santos AR, Fighera MR, Royes LF.
    Neurochem Int; 2013 Nov 15; 63(6):583-93. PubMed ID: 24076474
    [Abstract] [Full Text] [Related]

  • 11. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    He Q, Koprich JB, Wang Y, Yu WB, Xiao BG, Brotchie JM, Wang J.
    Mol Neurobiol; 2016 May 15; 53(4):2258-68. PubMed ID: 25972237
    [Abstract] [Full Text] [Related]

  • 12. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
    Kumar A, Leinisch F, Kadiiska MB, Corbett J, Mason RP.
    Mol Neurobiol; 2016 Jul 15; 53(5):2983-2994. PubMed ID: 25952542
    [Abstract] [Full Text] [Related]

  • 13. Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.
    Che Y, Hou L, Sun F, Zhang C, Liu X, Piao F, Zhang D, Li H, Wang Q.
    Cell Death Dis; 2018 Apr 01; 9(4):435. PubMed ID: 29568078
    [Abstract] [Full Text] [Related]

  • 14. Post-treatment of an NADPH oxidase inhibitor prevents seizure-induced neuronal death.
    Kim JH, Jang BG, Choi BY, Kim HS, Sohn M, Chung TN, Choi HC, Song HK, Suh SW.
    Brain Res; 2013 Mar 07; 1499():163-72. PubMed ID: 23313582
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.
    Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS.
    Aging Cell; 2010 Apr 07; 9(2):135-46. PubMed ID: 20041858
    [Abstract] [Full Text] [Related]

  • 16. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG, Bensadoun JC, Aebischer P, Schneider BL.
    J Parkinsons Dis; 2011 Apr 07; 1(4):373-87. PubMed ID: 23939344
    [Abstract] [Full Text] [Related]

  • 17. Unilateral intranigral administration of β-sitosterol β-D-glucoside triggers pathological α-synuclein spreading and bilateral nigrostriatal dopaminergic neurodegeneration in the rat.
    Soto-Rojas LO, Martínez-Dávila IA, Luna-Herrera C, Gutierrez-Castillo ME, Lopez-Salas FE, Gatica-Garcia B, Soto-Rodriguez G, Bringas Tobon ME, Flores G, Padilla-Viveros A, Bañuelos C, Blanco-Alvarez VM, Dávila-Ayala J, Reyes-Corona D, Garcés-Ramírez L, Hidalgo-Alegria O, De La Cruz-López F, Martinez-Fong D.
    Acta Neuropathol Commun; 2020 Apr 22; 8(1):56. PubMed ID: 32321590
    [Abstract] [Full Text] [Related]

  • 18. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation.
    Zhang W, Gao JH, Yan ZF, Huang XY, Guo P, Sun L, Liu Z, Hu Y, Zuo LJ, Yu SY, Cao CJ, Wang XM, Hong JS.
    Mol Neurobiol; 2018 Jan 22; 55(1):619-632. PubMed ID: 27975175
    [Abstract] [Full Text] [Related]

  • 19. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B, Zhang YX, Zhou HX, Sun FW, Zhang ZF, Wei Z, Zhang CY, Si DW.
    J Neurol Sci; 2015 Jan 15; 348(1-2):142-52. PubMed ID: 25491263
    [Abstract] [Full Text] [Related]

  • 20. A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats.
    Zhou Y, Zhang Y, Li J, Lv F, Zhao Y, Duan D, Xu Q.
    J Neurochem; 2012 Dec 15; 123(5):771-80. PubMed ID: 22957701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.